Do digital technologies reduce racially biased reporting? Evidence from NYPD administrative data.

Recent work has emphasized the disproportionate bias faced by minorities when interacting with law enforcement. However, research on the topic has been hampered by biased sampling in administrative data, namely that records of police interactions with citizens only reflect information on the civilians that police elect to investigate, and not civilians that police observe but do not investigate. In this work, we address a related bias in administrative police data which has received less empirical attention, namely reporting biases around investigations that have taken place. Further, we investigate whether digital monitoring tools help mitigate this reporting bias. To do so, we examine changes in reports of interactions between law enforcement and citizens in the wake of the New York City Police Department's replacement of analog memo books with mobile smartphones. Results from a staggered difference in differences estimation indicate a significant increase in reports of citizen stops once the new smartphones are deployed. Importantly, we observe that the rise is driven by increased reports of "unproductive" stops, stops involving non-White citizens, and stops occurring in areas characterized by a greater concentration of crime and non-White residents. These results reinforce the recent observation that prior work has likely underestimated the extent of racial bias in policing. Further, they highlight that the implementation of digital monitoring tools can mitigate the issue to some extent.

The path to Net Zero carbon emissions for veterinary practice.

The urgent need to reduce greenhouse gas emissions in line with the Paris Agreement is a compelling reason for the entire veterinary profession to act on climate change because of its impact on animal health. The aim of this perspective is to provide a business framework that veterinary practices can use to implement the path to Net Zero carbon emissions. Practice management is identified as a key stakeholder capable of implementing significant change within the sector. Climate related business opportunities and challenges are identified and integrated into a stepwise process for practices to follow. The pathway requires establishing a culture of sustainability within the veterinary team, measuring and reporting emissions, setting targets and systematically prioritizing reductions. Practices can begin this process immediately by reducing emissions under direct control of the business (Scope 1) and emissions from electricity purchases (Scope 2). To complete the pathway, emissions from all other activities (Scope 3) will need to be reduced and offset. Reduction of Scope 3 emissions is more challenging and will require collaboration between all supply chain stakeholders. The progression of climate change is now inevitable and a proactive approach from veterinary leaders, in particular practice management, will provide new opportunities, manage risks and inspire the broader veterinary sector to join their efforts to achieve a better future for animal health.

Anesthesia Medications and Interaction with Chemotherapeutic Agents.

Cancer is now a leading health concern worldwide. In an effort to provide these patients with adequate care, coordination between anesthesiologists and surgeons is crucial. In cancer-related treatment, it is very clear that radio-chemotherapy and medical procedures are important. There are some obstacles to anesthesia when dealing with cancer treatment, such as physiological disturbances, tumor-related symptoms, and toxicity in traditional chemotherapy treatment. Therefore, it is important that a multisystemic, multidisciplinary and patient-centered approach is used to preserve perioperative homeostasis and immune function integrity. Adding adjuvants can help increase patient safety and satisfaction and improve clinical efficacy. Correctly paired anesthetic procedures and medications will reduce perioperative inflammatory and immune changes that could potentially contribute to improved results for future cancer patients. Further research into best practice strategies is required which will help to enhance the acute and long-term effects of cancer care in clinical practice.